CompoAtlas

Pure Performance 100% Clean Mass Gainer Vanilla Flavour

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Isolat de protéine de lactosérum

Fonte : Bos taurus - Lait

Potenza : 90 % Whey protein

2,03 gNon calcolata
Caséinate de calcium

Fonte : Bos taurus - Lait

Potenza : 88,5 % Protein

229,25 mgNon calcolata
Hydrolysat de protéine du lactosérum

Fonte : Bos taurus - Lait

Potenza : 75 % Whey protein

1,15 gNon calcolata
Concentré de protéine de lactosérum

Fonte : Bos taurus - Lait

Potenza : 85 % Whey protein

3,1 gNon calcolata
Protéine de pois

Fonte : Protéine de pois

Potenza : 82 % Protein

3,5 gNon calcolata
N-(Aminoiminométhyl)-N-méthylglycine monohydraté

Fonte : Créatine monohydratée

0,75 gNon calcolata
Maltodextrine

Fonte : Maltodextrin

33,625 gNon calcolata
Linum usitatissimum

Fonte : Graine(s)

2,75 mgNon calcolata
Extrait de fève de café vert

Fonte : Coffea canephora - Graine

Estratto : Matériel brut sec

Rapporto di estrazione : 10:1

Equivalente di pianta secca : 552,5 mg

Potenza : 45 % Chlorogenic acids

55,25 mgNon calcolata
Medicago sativa

Fonte : Sommité

0,475 mgNon calcolata
Bifidobacterium animalis subsp. lactis

Fonte : BL-04

0,1375 mgNon calcolata
Bifidobacterium animalis subsp. lactis

Fonte : Cellule entière

0,1375 mgNon calcolata
Lactobacillus acidophilus

Fonte : LA-14

0,35 mgNon calcolata
Lactobacillus acidophilus

Fonte : Cellule entière

0,35 mgNon calcolata
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fonte : Aspergillus niger - En entier

2,75 mgNon calcolata
Protéase fongique

Fonte : Aspergillus niger - En entier

2,75 mgNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Alpha-amylase

0,55 mgNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Aspergillus niger - En entier

0,55 mgNon calcolata
Triacylglycérol lipase

Fonte : Aspergillus niger - En entier

0,0175 mgNon calcolata
Papaïne

Fonte : Carica papaya - fruit

25,75 mgNon calcolata
Isolat de protéine de lait

Fonte : Bos taurus - Lait

Potenza : 80 % Protein

0,925 gNon calcolata
Isolat de protéine de boeuf

Fonte : Bos taurus - Muscle

Potenza : 95 % Protein

0,925 gNon calcolata
Micelles de caséine

Fonte : Micellar casein

Potenza : 81 % Protein

229,25 mgNon calcolata
Micelles de caséine

Fonte : Bos taurus - Lait

Potenza : 81 % Protein

229,25 mgNon calcolata
Colostrum bovin

Fonte : Bos taurus - colostrum

18,25 mgNon calcolata
Caséine, sel de sodium

Fonte : Bos taurus - Lait

Potenza : 85 % Protein

18,25 mgNon calcolata
Caséine, sel de sodium

Fonte : Sodium caseinate

Potenza : 85 % Protein

18,25 mgNon calcolata
Astragalus membranaceus

Fonte : Racine

6,25 mgNon calcolata
Panax notoginseng

Fonte : Racine

6,25 mgNon calcolata
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fonte : Aspergillus niger - En entier

13,75 FCC CUNon calcolata
Lactobacillus acidophilus

Fonte : LA-14

0,07 Milliards d'UFCNon calcolata
Lactobacillus acidophilus

Fonte : Cellule entière

0,07 Milliards d'UFCNon calcolata
Triacylglycérol lipase

Fonte : Aspergillus niger - En entier

1,375 FCC LUNon calcolata
Bifidobacterium animalis subsp. lactis

Fonte : BL-04

0,07 Milliards d'UFCNon calcolata
Bifidobacterium animalis subsp. lactis

Fonte : Cellule entière

0,07 Milliards d'UFCNon calcolata
Protéase fongique

Fonte : Aspergillus niger - En entier

138 Unités d'hémoglobine basées sur la tyrosine, du FCCNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Alpha-amylase

41,5 Unités d'alpha-amylase dextrinifiante du FCCNon calcolata
4-alpha-D-glucane glucanohydrolase

Fonte : Aspergillus niger - En entier

41,5 Unités d'alpha-amylase dextrinifiante du FCCNon calcolata
Papaïne

Fonte : Carica papaya - fruit

2.530,75 Unités de papaïne du FCCNon calcolata

Ingredienti non medicinali

Poudre de germe d'amaranthe, Gomme de Guar, Poudre de germe de sarrasin, Sucralose, Dioxyde de silicium, Gomme de xanthane, Mélange de germes, Acacia, Feuille de Stevia rebaudiana, Saveur de vanille, Poudre de germe de quinoa, Maltodextrine, Millet, Chlorure de sodium, Son d'Avena sativa (Avoine), Extrait de fruit de monk, Albumen

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
Adultesminimum : 19 ans1 Mesures4 jours

Usi autorizzati in Canada

Increases muscle size when used in conjunction with a resistance training regimen. Improves strength and power in repetitive bouts of brief, highly-intense physical activity. Source of calories which contributes to weight gain. Source of carbohydrates to support energy production. Helps to [maintain performance/promote endurance] in extended (greater than 60 min), high intensity exercise. Source of (all) essential amino acids (i.e. histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine) for the maintenance of good health. Source of branched chain amino acids for the maintenance of good health. Source of (essential) amino acids involved in muscle protein synthesis. (Excellent) Source of protein for the maintenance of good health. (Excellent) Source of protein which helps build and repair body tissues. (Excellent) Source of protein which helps build antibodies. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of digestive enzymes. Source of enzymes that help digest proteins.

Testo originale in inglese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Known Adverse Reactions : This product may cause mild gastrointestinal disturbances. Hypersensitivity/allergy has been known to occur; in which case, discontinue use.

Testo originale in inglese.

Contra-Indications : If you have a known allergy/hypersensitivity to cow's milk, do not use this product. Do not use if you are pregnant or breastfeeding. Do not use if you have a history of systemic lupus erythematosus. If you have an immune system disorder (eg. AIDS, Crohn's Disease, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, systematic lupus, erythematosus, patients undergoing long-term corticosteroid treatment), a history if systematic lupus erythematosus or are taking immunosuppressants, do not use this product.

Testo originale in inglese.

Cautions and Warnings : Ensure to drink enough fluid before, during, and after exercise. May result in weight gain. If you have liver or kidney disease or if you have been instructed to follow a low protein diet, consult a health care practitioner prior to use. If you have a history of cancer, consult a healthcare practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato), consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you are undergoing hormone replacement therapy (HRT) or taking birth control medication. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. This product contains milk by-products/derivatives.

Testo originale in inglese.

Scheda del prodotto

Titolare
Wellnx Life Sciences Inc./ Altrex Nutrition/ Wellnx Distribution Inc.
NPN o DIN-HM
80087098
Stato
Licenza attiva
Data della licenza
16 luglio 2018
Data di revisione
Non indicata
Forma
Poudre
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80087098

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Linum usitatissimum
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    FLAXSEED - LINUM USITATISSIMUM

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Si applica ai prodotti: providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Fonti citate da Health Canada (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Condizione di applicazione: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Fonti citate da Health Canada (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Controindicazioni

    Si applica ai prodotti: providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Fonti citate da Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Reazioni avverse note

    Condizione di applicazione: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Fonti citate da Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Monografia di Health Canada del 26 luglio 2024

  • Medicago sativa
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    ALFALFA - MEDICAGO SATIVA

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Si applica ai prodotti: providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Fonti citate da Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Controindicazioni

    Condizione di applicazione: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Fonti citate da Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Si applica ai prodotti: providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Fonti citate da Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Monografia di Health Canada del 29 novembre 2024

  • Astragalus membranaceus
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Fonti citate da Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Controindicazioni

    Condizione di applicazione: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Fonti citate da Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Monografia di Health Canada del 30 maggio 2025

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga